Skip to main content
Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.145
+0.065 (3.12%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Compugen Revenue

In the year 2025, Compugen had annual revenue of $72.76M with 161.14% growth. Compugen had revenue of $67.33M in the quarter ending December 31, 2025, with 4,477.29% growth.

Revenue (ttm)
$72.76M
Revenue Growth
+161.14%
P/S Ratio
2.69
Revenue / Employee
$983,297
Employees
74
Market Cap
201.40M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202572.76M44.90M161.14%
Dec 31, 202427.86M-5.60M-16.72%
Dec 31, 202333.46M25.96M346.12%
Dec 31, 20227.50M1.50M25.00%
Dec 31, 20216.00M4.00M200.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Heron Therapeutics 154.90M
Arcturus Therapeutics Holdings 82.03M
Editas Medicine 46.38M
ProQR Therapeutics 18.86M
Molecular Partners AG 856.30K
NeOnc Technologies Holdings 59.99K
Revenue Rankings

CGEN News

More News